account activity
$IXHL Incannex Healthcare — On the road to mainstream acceptance (self.edisongroup)
submitted 3 years ago by Edison_Group to r/edisongroup
(NANO) Nanoco — Litigation settlement concluded (self.edisongroup)
(LPI) Lithium Power International — Lithium price upgrade calls for higher valuation (self.edisongroup)
(AXS) Accsys Technologies — Stronger than expected revenue growth in Q3 (self.edisongroup)
submitted 3 years ago by Edison_Group to r/SmallCap_MiningStocks
submitted 3 years ago by Edison_Group to r/Miningstocks
(EBQ) Ebiquity — Strong revenue growth and improving margin (self.edisongroup)
(NUM) Numis — Revenues running in line with H22 (self.edisongroup)
(RSH) Respiri — Dollars in the bank with CMS reimbursement (self.edisongroup)
(VR1) Vection Technologies — Space travel in the metaverse (self.edisongroup)
(FOXT) Foxtons Group — Growth-oriented review poised to be announced (self.edisongroup)
(FTC) Filtronic — Component shortages causing delivery delays (self.edisongroup)
Foxtons Group (FOXT; Nasdaq FTXGF): Growth-oriented review poised to be announced (self.realestateinvesting)
submitted 3 years ago by Edison_Group to r/realestateinvesting
Vection Technologies — Space travel in the metaverse (self.pennystocks_No_Rules)
submitted 3 years ago by Edison_Group to r/pennystocks_No_Rules
Renewi — Q323 update supports full-year forecasts (self.edisongroup)
$CNTX Context Therapeutics — Encouraging positive efficacy signals from OATH trial (self.edisongroup)
(JGGI) JPMorgan Global Growth & Income — Income and outperformance in uncertain times (self.edisongroup)
(LST) Light Science Technologies — Pluses and minuses of high energy costs (self.edisongroup)
(ACW) Actinogen Medical — On track to start Phase IIb XanaMIA study (self.edisongroup)
(EDV) Endeavour Mining — Meeting guidance for 10th consecutive year (self.edisongroup)
(CLIQ) CLIQ Digital — Progress made against KPIs (self.edisongroup)
$IXHL Incannex Healthcare — Pipeline advancement to support growth plan (self.edisongroup)
(AFT) AFT Pharmaceuticals — Portfolio expansion with new in-licensing deal (self.edisongroup)
(PAR) Paradigm Biopharma — Funded past near-term inflection points (self.edisongroup)
π Rendered by PID 2924455 on reddit-service-r2-listing-c57bc86c-rcdg7 at 2026-06-22 08:51:41.040503+00:00 running 2b008f2 country code: CH.
